Journal of Oncology Practice, Vol 2, No 6 (November), 2006: pp. 265-267
© 2006
American Society of Clinical Oncology.
DOI: 10.1200/JOP.2.6.265
Developing an Effective and Compliant Plan for Billing Clinical Trials
Lisa R. Pitler, JD, MS, RN,
Philip D. Bonomi, MD
| Because this article has no abstract, we have provided an extract of the first 100 words of the full text.
|
| |
Lisa R. Pitler, JD, MS, RN
|
|
| |
Philip D. Bonomi, MD
|
|
Medicare's financial coverage for clinical trial participants and potential overpayments for items and services provided to patients in clinical trials are significant issues that, if not addressed, could compromise the ability to conduct clinical research. As financial pressure on the Centers for Medicare & Medicaid Services (CMS) resources increases, there is greater scrutiny on payments made by CMS. Errors in billing Medicare for items or services rendered in clinical trials could trigger allegations under the False Claims Act (which provides for an action for presenting a false claim to the . . . [Click for More]
Related articles in JOP:
- Navigating the Clinical Trial Billing Maze
- James B. Pfadenhauer
JOP 2006 2: 280.
[Extract]
[Full Text]
- Mandated Clinical Trial Coverage Varies Across States
JOP 2007 3: 31-32.
[Extract]
[Full Text]
|